MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12916-022-02319-y

Медицинская библиотека · BMC medicine · 2022

Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.

Cairat Manon, Rinaldi Sabina, Navionis Anne-Sophie, Romieu Isabelle, Biessy Carine, Viallon Vivian, Olsen Anja, Tjønneland Anne, Fournier Agnès, Severi Gianluca, Kvaskoff Marina, Fortner Renée T, Kaaks Rudolf, Aleksandrova Krasimira, Schulze Matthias B, Masala Giovanna, Tumino Rosario, Sieri Sabina, Grasso Chiara, Mattiello Amalia, Gram Inger T, Olsen Karina Standahl, Agudo Antonio, Etxezarreta Pilar Amiano, Sánchez Maria-Jose, Santiuste Carmen, Barricarte Aurelio, Monninkhof Evelyn, Hiensch Anouk E, Muller David, Merritt Melissa A, Travis Ruth C, Weiderpass Elisabete, Gunter Marc J, Dossus Laure

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Inflammation has been hypothesized to play a role in the development and progression of breast cancer and might differently impact breast cancer risk among pre and postmenopausal women. We performed a nested case-control study to examine whether pre-diagnostic circulating concentrations of adiponectin, leptin, c-reactive protein (CRP), tumour necrosis factor-α, interferon-γ and 6 interleukins were associated with breast cancer risk, overall and by menopausal status.

METHODS

Pre-diagnostic levels of inflammatory biomarkers were measured in plasma from 1558 case-control pairs from the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. We used conditional logistic regression to estimate the odds ratios (ORs) of breast cancer at blood collection, per one standard deviation increase in biomarker concentration.

RESULTS

Cases were diagnosed at a mean age of 61.4 years on average 8.6 years after blood collection. No statistically significant association was observed between inflammatory markers and breast cancer risk overall. In premenopausal women, borderline significant inverse associations were observed for leptin, leptin-to-adiponectin ratio and CRP [OR= 0.89 (0.77-1.03), OR= 0.88 (0.76-1.01) and OR= 0.87 (0.75-1.01), respectively] while positive associations were observed among postmenopausal women [OR= 1.16 (1.05-1.29), OR= 1.11 (1.01-1.23), OR= 1.10 (0.99-1.22), respectively]. Adjustment for BMI strengthened the estimates in premenopausal women [leptin: OR = 0.83 (0.68-1.00), leptin-to-adiponectin ratio: OR = 0.80 (0.66-0.97), CRP: OR = 0.85 (0.72-1.00)] but attenuated the estimates in postmenopausal women [leptin: OR = 1.09 (0.96-1.24), leptin-to-adiponectin ratio: OR = 1.02 (0.89-1.16), CRP: OR = 1.04 (0.92-1.16)].

CONCLUSIONS

Associations between CRP, leptin and leptin-to-adiponectin ratio with breast cancer risk may represent the dual effect of obesity by menopausal status although this deserves further investigation.

Для цитирования: Cairat Manon, Rinaldi Sabina, Navionis Anne-Sophie, Romieu Isabelle, Biessy Carine, Viallon Vivian, Olsen Anja, Tjønneland Anne, Fournier Agnès, Severi Gianluca, Kvaskoff Marina, Fortner Renée T, Kaaks Rudolf, Aleksandrova Krasimira, Schulze Matthias B, Masala Giovanna, Tumino Rosario, Sieri Sabina, Grasso Chiara, Mattiello Amalia, Gram Inger T, Olsen Karina Standahl, Agudo Antonio, Etxezarreta Pilar Amiano, Sánchez Maria-Jose, Santiuste Carmen, Barricarte Aurelio, Monninkhof Evelyn, Hiensch Anouk E, Muller David, Merritt Melissa A, Travis Ruth C, Weiderpass Elisabete, Gunter Marc J, Dossus Laure. Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohort.. BMC medicine. 2022. DOI: 10.1186/s12916-022-02319-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.